Trevena Inc (TRVN)

NASDAQ
1.8800
-0.0200(-1.05%)
After Hours
1.8800
0.0000(0.00%)
- Real-time Data
  • Volume:
    1,507,074
  • Bid/Ask:
    1.8800/1.9000
  • Day's Range:
    1.8600 - 1.9300

TRVN Overview

Prev. Close
1.88
Day's Range
1.86-1.93
Revenue
3.28M
Open
1.92
52 wk Range
1.34-3.68
EPS
-0.25
Volume
1,507,074
Market Cap
307.56M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,072,495
P/E Ratio
-
Beta
2.45
1-Year Change
13.25%
Shares Outstanding
163,593,457
Next Earnings Date
Aug 05, 2021
What is your sentiment on Trevena Inc?
or
Market is currently closed. Voting is open during market hours.

Trevena Inc News

Trevena Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellNeutral
Technical IndicatorsBuyBuyStrong SellStrong SellBuy
SummaryNeutralNeutralStrong SellStrong SellNeutral

Trevena Inc Company Profile

Trevena Inc Company Profile

Employees
0

Trevena Inc. is a biopharmaceutical company, which is engaged in developing various therapies. The Company is developing OLINVO, a u-receptor G protein pathway selective modulator (u-GPS) for the management of moderate-to-severe acute pain where intravenous (IV) administration is preferred. It is focused on commercializing it in the United States for use in acute care settings, such as hospitals and ambulatory surgery centers. It is also developing TRV250, a G protein biased ligand targeting the o-receptor, as a compound with a non-narcotic mechanism for the treatment of migraine. TRV250 also may have utility in a range of other central nervous system (CNS) indications. It is focused on commencing a Phase I study of TRV250 in the United Kingdom. Its ABLE product platform is a collection of biological information, in vitro assays, know-how and expertise that it uses to identify unique G protein coupled receptors (GPCR)-targeted biased ligands with various pharmaceutical properties.

Read More
  • Very interesting to see what they do with all that cash. They've been definitely using it according to increase in liabilities. Very liquid, no debt.
    0
    • anyone long?
      0
      • is there any news ?
        0
        • i am not used to see this stock positive for a while.
          0
        • agreed
          0
        • https://www.google.com/amp/s/seekingalpha.com/amp/article/4400684-trevenas-catalyst-filled-q1
          0
      • Lets hit the 4 and then 7, that would make my day :)
        0
        • Boo
          0
          • Whats ur thoughts on this one guys? Ever gonna shine?
            0
            • dont think so in short term
              0
          • https://www.trevena.com/investors/press-releases/detail/244/trevena-inc-announces-dea-scheduling-of-olinvyk
            0
            • $5 in November.2021 is where the real growth will start. BUY
              1
              • About time this things does something!
                0
                • is it supposed to keep going down
                  0
                  • what is happening???
                    0
                    • what is happening???
                      0
                      • Crossing $3$4 next month and soon $5 too
                        1
                        • It will cross $5 soon...
                          0
                          • We are still far away from the target price of $6. If you wanna earm some quick money then invest in this company. 2021 is a big profit year!
                            0
                            • this will explode next 2 weeks
                              1
                              • It has been 2 weeks.,
                                0
                              • i know, i hope you listened...
                                0
                              • Zack Lewislol ********of a call
                                0
                            • As a healthcare worker myself this med should take off well. Im not great at the market but many patients end up with pneumonia from decreased respirations from opiates in hospitals. Hospitals trying to save money from hospital aquired pneumonia would love this just to save money. Im holding on , i think it will go up after it gets into yhe hands of hospitals. I hope they dont take to long roll it out. Much needed med.
                              2
                              • https://www.trevena.com/investors/press-releases/detail/240/trevena-announces-publications-of-olinvyk-respiratory
                                0
                                • Are we just bag holding here? FDA approval and the stock goes down instead of up lmao what a joke this is.
                                  0
                                  • I think they just down talk it up enough. It should jump but think its a hold for now waiting for the spike. I think they dont talk just so it goes down but who knows. Im actualy buying down trends for the spike or a wash , one of the two
                                    0
                                  • More i think about it. China can be manipulating it. They gave Them 3 million to start. They are probably dropping the price before giving them more money to pay less for the stock. Just a theory
                                    0
                                  • Already jumped ship at a small loss, I'm not riding this to 0.
                                    0
                                • grounding incoming
                                  0
                                  • What the ***is happening here with Trevena?
                                    0
                                    • Good question
                                      0
                                    • Hopefully it changes today
                                      0
                                  • Hopefully we see some good results after the 90-day scheduling. https://www.fiercepharma.com/marketing/trevena-preps-low-key-launch-for-finally-approved-opioid-olinvyk-promises-responsible
                                    0
                                    • Public offering of common stock over?
                                      0
                                      • Trevena Announces Pricing of $50 Million Public Offering of Common Stock
                                        1
                                        • sec filing 8-k Trevena Announces Proposed Public Offering of Common Stock
                                          0
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.